The Ophthalmic drug industry grosses over $1.8 billion Canadian annually and is the fastest growing segment of the Canadian pharmaceutical industry. Genix’s plan in the future is to research ocular herbal products and acquire an additional 70-100 ophthalmic drug products over the next 3 years.
The Opportunity
Market Overview
Corporate Governance And Compensation Committee Charter
Stay In Touch
Trade Alert – Delivering the latest product trends and industry news straight to your inbox.